Primary Site >> Esophagus Cancer

Gene >> PLAU

  • 1993
  • 1998
  • 1999
  • 2001
  • 2002
  • 2007
  • 2008
  • 2010
  • 2012
  • 2014
Ref: Carcinomatous invasion and lymphocyte infiltration in early esophageal carcinoma with special regard to the basement membrane. An immunohistochemical study.
PMID: 8325587
Ref: Strong prognostic impact of tumor-associated urokinase-type plasminogen activator in completely resected adenocarcinoma of the esophagus.
PMID: 9676852
Ref: Invasion by esophageal cancer cells: functional contribution of the urokinase plasminogen activation system, and inhibition by antisense oligonucleotides to urokinase or urokinase receptor.
PMID: 10390151
Ref: Serine proteinase activation in esophageal cancer.
PMID: 11724279
Ref: Significance of plasminogen-activation system in the formation of macroscopic types and invasion in esophageal carcinoma.
PMID: 12530017
Ref: ECRG2 inhibits cancer cell migration, invasion and metastasis through the down-regulation of uPA/plasmin activity.
PMID: 17602171
Ref: FAP-alpha and uPA show different expression patterns in premalignant and malignant esophageal lesions.
PMID: 18570153
Ref: Mapping the putative binding site for uPA protein in Esophageal Cancer-Related Gene 2 by heteronuclear NMR method.
PMID: 18824154
Ref: Molecular cloning and characterization of a novel esophageal cancer related gene.
PMID: 21042721
Ref: Relationships of uPA and VEGF expression in esophageal cancer and microvascular density with tumorous invasion and metastasis.
PMID: 22994764
Ref: High GPX1 expression promotes esophageal squamous cell carcinoma invasion, migration, proliferation and cisplatin-resistance but can be reduced by vitamin D.
PMID: 25356106